Actively Recruiting
Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery
Led by Shanghai Chest Hospital · Updated on 2026-04-13
204
Participants Needed
1
Research Sites
38 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective, randomized controlled study aims to evaluate the efficacy and safety of electroacupuncture combined with 5-HT3 receptor inhibitor for preventing postoperative nausea and vomiting (PONV) in high-risk patients undergoing thoracoscopic lung cancer surgery. The primary outcome is the incidence of PONV within 24 hours after surgery.
CONDITIONS
Official Title
Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- American Society of Anesthesiologists (ASA) physical status I-III
- Body mass index (BMI) between 18 and 30 kg/m²
- Scheduled for elective video-assisted thoracoscopic surgery (VATS) lobectomy, segmentectomy, or wedge resection
- Expected to receive postoperative opioid pain medication and have an Apfel risk score of 3 or higher
- Normal lung function without severe cardiovascular, liver, or kidney problems
- No infection near acupuncture sites
- Provided voluntary written informed consent
You will not qualify if you...
- Severe systemic diseases like serious heart, liver, or kidney problems, or poor lung function
- Cognitive dysfunction or psychological disorders
- Previous esophageal or stomach surgery
- Allergic reactions to acupuncture or study medications
- Severe infection or past surgery near acupuncture sites
- Pregnant or breastfeeding women
- Long-term opioid use
- Conversion to open surgery during procedure
- Received acupuncture treatment within 1 month before enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Chest Hospital
Shanghai, China
Actively Recruiting
Research Team
D
Deputy Chief Physician
CONTACT
C
Chief Physician
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here